Biden Administration Suspends Trump Order to Lower Insulin, Epinephrine Prices

Biden Administration Suspends Trump Order to Lower Insulin, Epinephrine Prices
EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company for use by severe allergy sufferers are seen in Washington, U.S. on August 24, 2016. REUTERS/Jim Bourg/File Photo
Jack Phillips
Updated:

The Biden administration has paused a rule put in place by former President Donald Trump that would allow community health centers to pass on all their insulin and epinephrine savings to patients.

According to a Federal Register (pdf) post, “this action temporarily delays for 60 days from the date of the memorandum the effective date of the final rule titled ‘Implementation of Executive Order on Access to Affordable Life-saving Medications,’ published” in December 2020.
Jack Phillips
Jack Phillips
Breaking News Reporter
Jack Phillips is a breaking news reporter who covers a range of topics, including politics, U.S., and health news. A father of two, Jack grew up in California's Central Valley. Follow him on X: https://twitter.com/jackphillips5
twitter
Related Topics